HK1088592A1 - Crystalline salts of dodecyl 2-(N,N-D-dimethylamino)-propionate - Google Patents

Crystalline salts of dodecyl 2-(N,N-D-dimethylamino)-propionate

Info

Publication number
HK1088592A1
HK1088592A1 HK06108943A HK06108943A HK1088592A1 HK 1088592 A1 HK1088592 A1 HK 1088592A1 HK 06108943 A HK06108943 A HK 06108943A HK 06108943 A HK06108943 A HK 06108943A HK 1088592 A1 HK1088592 A1 HK 1088592A1
Authority
HK
Hong Kong
Prior art keywords
dimethylamino
propionate
dodecyl
crystalline salts
crystalline
Prior art date
Application number
HK06108943A
Other languages
English (en)
Inventor
Servet Buyuktimkin
Nadir Buyuktimkin
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of HK1088592A1 publication Critical patent/HK1088592A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Paper (AREA)
  • Holo Graphy (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HK06108943A 1999-05-19 2001-11-29 Crystalline salts of dodecyl 2-(N,N-D-dimethylamino)-propionate HK1088592A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/314,571 US6118020A (en) 1999-05-19 1999-05-19 Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
HK01108398A HK1037607A1 (en) 1999-05-19 2001-11-29 Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate

Publications (1)

Publication Number Publication Date
HK1088592A1 true HK1088592A1 (en) 2006-11-10

Family

ID=23220476

Family Applications (2)

Application Number Title Priority Date Filing Date
HK01108398A HK1037607A1 (en) 1999-05-19 2001-11-29 Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
HK06108943A HK1088592A1 (en) 1999-05-19 2001-11-29 Crystalline salts of dodecyl 2-(N,N-D-dimethylamino)-propionate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK01108398A HK1037607A1 (en) 1999-05-19 2001-11-29 Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate

Country Status (22)

Country Link
US (1) US6118020A (xx)
EP (2) EP1097126B1 (xx)
JP (1) JP4864208B2 (xx)
KR (1) KR100688920B1 (xx)
CN (3) CN1837187A (xx)
AT (1) ATE272607T1 (xx)
AU (1) AU781427B2 (xx)
BR (1) BR0006133A (xx)
CA (2) CA2338139C (xx)
CY (1) CY1113331T1 (xx)
DE (1) DE60012656T2 (xx)
DK (2) DK1097126T3 (xx)
ES (2) ES2223524T3 (xx)
HK (2) HK1037607A1 (xx)
HU (1) HU230508B1 (xx)
IL (1) IL140569A (xx)
MX (1) MXPA01000669A (xx)
PT (2) PT1097126E (xx)
SI (1) SI1097126T1 (xx)
TW (1) TWI256949B (xx)
WO (1) WO2000069809A1 (xx)
ZA (1) ZA200100142B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6414028B1 (en) * 1997-11-05 2002-07-02 Nexmed Holdings, Inc. Topical compositions containing prostaglandin E1
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
IL142536A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Carriers for therapeutic preparations for treatment of t-cell mediated diseases
US8987263B2 (en) 2002-10-10 2015-03-24 Meir Shinitzky Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
MXPA05010068A (es) * 2003-03-21 2005-11-23 Nexmed Holdings Inc Promocion de la angiogenesis por composiciones de prostaglandina y metodos.
DE602004021253D1 (de) 2003-03-21 2009-07-09 Nexmed Holdings Inc Antimykotischer nagellack und anwendungsverfahren
KR20050119134A (ko) * 2003-03-21 2005-12-20 넥스메드 홀딩스 인코포레이티드 발기 부전 치료용 프로스타글란딘 조성물
CA2520347A1 (en) * 2003-04-02 2004-10-21 Nexmed Holdings, Inc. Prostaglandin compositions and their use for the treatment of vasospasm
US7964751B2 (en) * 2007-02-26 2011-06-21 Yeda Research And Development Co. Ltd. Enantiomers of amino-phenyl-acetic acid octadec-9-(Z) enyl ester, their salts and their uses
EP2117301A4 (en) * 2007-02-26 2010-04-14 Yeda Res & Dev USE OF LONG-CHAINED ALCOHOL DERIVATIVES FOR THE TREATMENT OF CIRCULAR HAIR LOSS
CA3027255C (en) 2009-07-10 2022-06-21 The General Hospital Corporation Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
CA2784824A1 (en) * 2009-12-18 2011-06-23 Achelios Therapeutics Llc Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
CA2797966A1 (en) * 2010-05-04 2011-11-10 Nexmed Holdings, Inc. Therapeutic peptide composition and method
NZ602978A (en) * 2010-05-04 2014-10-31 Nexmed Holdings Inc Compositions of small molecule therapeutics
CA2811962A1 (en) * 2010-09-24 2012-03-29 Nexmed Holdings, Inc. Enhanced transbuccal drug delivery system and compositions
ES2801999T3 (es) * 2010-12-02 2021-01-15 Ferring Int Center Sa Enantiómero activo de 2-(N,N-dimetilamino)-propionato de dodecilo
WO2012097160A1 (en) * 2011-01-14 2012-07-19 Nexmed Holdings, Inc. Rectal delivery method for therapeutic peptides
WO2012139033A1 (en) 2011-04-07 2012-10-11 Nexmed Holdings, Inc. Methods and compositions for treating raynaud's disease
US8900625B2 (en) * 2012-12-15 2014-12-02 Nexmed Holdings, Inc. Antimicrobial compounds and methods of use
ES2613721T3 (es) 2012-12-21 2017-05-25 Teikoku Pharma Usa, Inc. Composiciones y métodos para administración transdérmica de hormonas y otros agentes medicinales
US20170266106A1 (en) 2014-12-01 2017-09-21 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
JP6833811B2 (ja) 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
JP2019532027A (ja) 2016-08-17 2019-11-07 ソルスティス バイオロジクス，リミティッド ポリヌクレオチド構築物
EP3645546A4 (en) 2017-06-30 2021-12-01 Solstice Biologics, Ltd. CHIRAL PHOSPHORAMIDITIS AUXILIARIES AND THEIR METHODS OF USE
CA3129117A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
EP3937945A4 (en) 2019-03-11 2023-01-04 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
US20220307013A1 (en) 2019-08-30 2022-09-29 The Regents Of The University Of California Gene fragment overexpression screening methodologies, and uses thereof
EP4054586A4 (en) 2019-11-06 2023-11-22 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
CA3155586A1 (en) 2019-11-06 2021-05-14 Bridget M. Cole Charged ion channel blockers and methods for use
CN115279731B (zh) 2020-03-11 2024-09-13 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980378A (en) * 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
JPH08311210A (ja) * 1995-05-24 1996-11-26 Dai Ichi Kogyo Seiyaku Co Ltd 樹脂成形体の導電性改良方法および静電塗装方法

Also Published As

Publication number Publication date
SI1097126T1 (en) 2004-10-31
CN1837187A (zh) 2006-09-27
CN1244546C (zh) 2006-03-08
CA2338139C (en) 2010-08-31
HK1037607A1 (en) 2002-02-15
CN1306502A (zh) 2001-08-01
KR100688920B1 (ko) 2007-03-09
KR20010071969A (ko) 2001-07-31
TWI256949B (en) 2006-06-21
CA2706680A1 (en) 2000-11-23
IL140569A (en) 2006-07-05
JP4864208B2 (ja) 2012-02-01
JP2002544253A (ja) 2002-12-24
US6118020A (en) 2000-09-12
EP1097126B1 (en) 2004-08-04
WO2000069809A1 (en) 2000-11-23
HU230508B1 (hu) 2016-09-28
EP1428816A1 (en) 2004-06-16
HUP0202090A3 (en) 2002-11-28
CA2338139A1 (en) 2000-11-23
DK1097126T3 (da) 2004-11-01
ATE272607T1 (de) 2004-08-15
DE60012656D1 (de) 2004-09-09
ES2223524T3 (es) 2005-03-01
CA2706680C (en) 2012-11-27
HUP0202090A2 (en) 2002-10-28
MXPA01000669A (es) 2002-07-02
EP1428816B1 (en) 2012-09-05
ZA200100142B (en) 2002-01-07
DE60012656T2 (de) 2005-08-11
CN1733706A (zh) 2006-02-15
AU5023200A (en) 2000-12-05
CY1113331T1 (el) 2016-06-22
CN1315783C (zh) 2007-05-16
PT1097126E (pt) 2004-11-30
IL140569A0 (en) 2002-02-10
BR0006133A (pt) 2001-04-03
DK1428816T3 (da) 2012-10-01
EP1097126A1 (en) 2001-05-09
ES2390952T3 (es) 2012-11-20
EP1097126A4 (en) 2002-08-28
PT1428816E (pt) 2012-09-27
AU781427B2 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
HK1037607A1 (en) Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
AUPR034000A0 (en) Aminoalcohol derivatives
AUPQ841300A0 (en) New aminoalcohol derivatives
AU4829500A (en) Dynamic forward error correction
AU2609800A (en) Optical sheets suitable for spreading light
AU2001258117A1 (en) Supports for photosensitizer formulations
AUPQ585000A0 (en) Aminoalcohol derivatives
AU2001295926A1 (en) Process for producign optically active ethyl
AU2001266399A1 (en) Oral drug composition containing a verapamil derivative as drug-absorption promotor
AU2002217878A1 (en) Printer with automatic positioning multiple-microprocessor
HU9902352D0 (en) Process for producing pravastatin by microbiological way
AU2002230609A1 (en) Aerodynamically light vaccine for active pulmonary immunization
AU2002213579A1 (en) Medicaments for treating dementia
AU2002218215A1 (en) Novel pleuromutilin derivatives
AU1488001A (en) Stabilized thyroxine compounds
AU2000265203A1 (en) 8-substituted tetracycline compounds
DK1073634T3 (da) Fremgangsmåde til fremstilling af enantiomerrent N-methyl-N[(1S)-1-phenyl-2-2((3S)-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid
NO20022574D0 (no) N¶ringsmiddel som innbefatter karnitin, som er egnet for å stimulere biosyntesen av polyumettede fettsyrer fra mettedefettsyrer som foreligger i n¶ringsmiddelet
AU1281801A (en) Novel method for preparing eicosapentaenoic acid ethyl ester
BR0107483A (pt) Processo para a preparação de um composto
AU2001232752A1 (en) Intermediates for biologically active compounds
AU4302700A (en) Automatic adjustment of a labeller
WO2001044144A3 (en) Process for the preparation of sodium salts of statins
AU4941900A (en) Doping of crystalline substrates
AU2001265949A1 (en) Transdermal therapeutical system with a reduced tendency of the active substanceto crystallize

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20200517